Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
公司代码TMCI
公司名称Treace Medical Concepts Inc
上市日期Apr 23, 2021
CEOTreace (John T)
员工数量477
证券类型Ordinary Share
年结日Apr 23
公司地址100 Palmetto Park Place
城市PONTE VEDRA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编32081
电话19043735940
网址https://www.treace.com/
公司代码TMCI
上市日期Apr 23, 2021
CEOTreace (John T)